Method, apparatus and system for formal planning and implementation of network strategies and architecture
    181.
    发明申请
    Method, apparatus and system for formal planning and implementation of network strategies and architecture 审中-公开
    网络策略和架构的正式规划和实施的方法,设备和系统

    公开(公告)号:US20050132027A1

    公开(公告)日:2005-06-16

    申请号:US10738840

    申请日:2003-12-16

    CPC classification number: H04L41/145

    Abstract: A method and system for formal planning and implementation of network strategies and architectures is disclosed. More specifically, according to an embodiment of the present invention, network services may be conceptually divided into a framework comprising vertical resources and services and horizontal resources and services. This framework may be used to determine a network's existing capabilities as well as to plan for the network's expansion and evolution. According to one embodiment, the vertical resources and services may comprise transport services capability architecture, virtual network capability architecture, security capability service architecture and quality of service architecture. The horizontal resources and services may include IP layered services architecture, core network services architecture and core network transport architecture.

    Abstract translation: 公开了一种正式规划和实施网络策略和架构的方法和系统。 更具体地,根据本发明的实施例,网络服务可以在概念上被划分为包括垂直资源和服务以及横向资源和服务的框架。 该框架可用于确定网络的现有能力以及规划网络的扩展和演进。 根据一个实施例,垂直资源和服务可以包括传输服务能力架构,虚拟网络能力架构,安全能力服务架构和服务质量架构。 横向资源和服务可能包括IP分层服务架构,核心网络服务架构和核心网络传输架构。

    Sterile aspiration/reinjection systems
    182.
    发明授权
    Sterile aspiration/reinjection systems 有权
    无菌抽吸/回注系统

    公开(公告)号:US06796957B2

    公开(公告)日:2004-09-28

    申请号:US10004525

    申请日:2001-10-23

    Abstract: The invention provides systems containing a sterile container for aspiration, filtering, treating and reinjection into a subject of a bodily fluid in a sterile environment. The systems are particularly designed to facilitate transfection of cells within the sterile container by gene therapy molecules and reinjection of the transfected cells into the donor at controlled depth in precisely controlled volumes such as is useful for revascularization of ischemic cardiac tissue. For injection, a pressure actuator, preferably hand-held, applies force to liquids held within the sterile container in precisely controlled increments, thereby expressing liquids through a hollow needle or injection catheter in precisely controlled microvolumes. The invention systems include a hand-held injection device with audible cues that correspond to an operator-selected injection volume and/or audible cues that correspond to needle penetration depth selected by the operator.

    Abstract translation: 本发明提供了包含用于在无菌环境中吸入,过滤,处理和再注入体液的受试者的无菌容器的系统。 该系统特别设计用于通过基因治疗分子促进无菌容器内的细胞的转染,并以受精的控制体积(例如对于缺血性心脏组织的血运重建有用)将被转染的细胞重新注入受控深度的供体。 对于注射,优选手持式压力致动器以精确控制的增量对保持在无菌容器内的液体施加力,从而通过中空针或注射导管在精确控制的微量体积中表达液体。 本发明系统包括手持式注射装置,其具有对应于操作者选择的注射体积和/或对应于由操作者选择的穿刺深度的可听到的线索的可听到的提示。

    Delay estimation for restructuring
    183.
    发明授权
    Delay estimation for restructuring 失效
    重组的延迟估计

    公开(公告)号:US06672776B1

    公开(公告)日:2004-01-06

    申请号:US08818498

    申请日:1997-03-14

    CPC classification number: G06F17/505

    Abstract: Provided are a method, article of manufacture, and apparatus for estimating delays of networks. An automated design system comprises a computer configured to identify a critical path in a network, calculate a delay for the technology-mapped version of the network, calculate a delay for the technology-independent version of the network, calculate a scale factor from the technology-mapped and technology-independent delays, and apply the scale factor to all the delays in the technology-independent network.

    Abstract translation: 提供了一种用于估计网络延迟的方法,制造品和装置。 自动设计系统包括被配置为识别网络中的关键路径的计算机,计算网络的技术映射版本的延迟,计算与技术无关版本的网络的延迟,从该技术计算比例因子 和技术无关的延迟,并将比例因子应用于与技术无关的网络中的所有延迟。

    Left atrium ablation catheter
    184.
    发明授权
    Left atrium ablation catheter 失效
    左心房消融导管

    公开(公告)号:US06200315B1

    公开(公告)日:2001-03-13

    申请号:US08993211

    申请日:1997-12-18

    Abstract: A left atrium ablation catheter (4), including a sheath (8) and a deflectable electrophysiology catheter (10) housed within the sheath, is used to ablate coronary tissue at a target site within the left atrium (LA) of a heart. The electrophysiology catheter has ablation electrodes (24) along the tip (10). The ablation catheter is introduced into the right atrium (RA) through either the superior vena cava (SVC) or the inferior vena cava (IVC). The distal open end of the sheath is guided through a punctured hole in the interatrial septum and into the left atrium. The distal end (20) of the sheath is either precurved or is steerable so the electrode tip can be directed to the coronary target site in the left atrium. The electrode tip is sized and configured to create the desired lesion at the target site without movement of the electrode tip.

    Abstract translation: 包括护套(8)和容纳在护套内的可偏转电生理学导管(10)的左心房消融导管(4)用于在心脏的左心房(LA)内的靶位置消融冠状组织。 电生理学导管具有沿尖端(10)的消融电极(24)。 消融导管通过上腔静脉(SVC)或下腔静脉(IVC)引入右心房(RA)。 护套的远端开口端引导穿过房间隔中的穿刺孔并进入左心房。 鞘的远端(20)是预先的或是可操纵的,使得电极尖端可以被引导到左心房中的冠状动脉靶位点。 电极头的尺寸和构造可以在靶位置产生所需的损伤,而不会移动电极尖端。

    Electronic chassis and filter apparatus and method
    185.
    发明授权
    Electronic chassis and filter apparatus and method 失效
    电子底盘和过滤装置及方法

    公开(公告)号:US6007169A

    公开(公告)日:1999-12-28

    申请号:US144829

    申请日:1998-08-31

    CPC classification number: H05K7/20181 H05K7/1425

    Abstract: An electronic chassis and filter apparatus is provided. A chassis includes a top portion, a bottom portion, a first side wall portion, and a second side wall portion. The bottom portion includes an open front side, a closed back side, a first guide rail portion and a second guide rail portion. An ejector spring is operatively attached to the back side of the bottom portion, and a spring-biased actuator is operatively connected to the first rail portion adjacent the open front side. When the filter is inserted into the open front side, the filter contacts the ejector spring which biases the filter against the spring-biased actuator.

    Abstract translation: 提供电子底盘和过滤装置。 底盘包括顶部,底部,第一侧壁部分和第二侧壁部分。 底部包括敞开的前侧,封闭的后侧,第一导轨部分和第二导轨部分。 顶出弹簧可操作地附接到底部的后侧,并且弹簧偏置致动器可操作地连接到邻近开放前侧的第一轨道部分。 当过滤器插入打开的前侧时,过滤器接触顶出弹簧,弹簧偏压过滤器抵靠弹簧偏置的致动器。

    Fluid cooled ablation catheter and method for making
    186.
    发明授权
    Fluid cooled ablation catheter and method for making 失效
    流体冷却消融导管及其制造方法

    公开(公告)号:US5913854A

    公开(公告)日:1999-06-22

    申请号:US794803

    申请日:1997-02-04

    Abstract: A catheter assembly (2) includes a catheter shaft (6) having a tip portion (10) with a hollow interior (30) and a linear ablation electrode (18, 34, 36, 44, 58) spaced apart from the distal end (22) of the tip portion. The electrode has an inner surface (28) which is effectively fluidly exposed to the hollow interior so that a cooling fluid (32) passing through the interior contacts the inner surface so to effectively cool the electrode. The electrode can include a series of band electrodes (18, 34) or one or more spiral electrodes (36, 44, 58). One method for making the tip portion involves mounting the electrode to a mandrel, filling the spaces between the edges (26) of the electrode with a polymer and then removing the resulting tubular structure from the mandrel. The cooling fluid can pass through a hollow spiral electrode (58) for enhanced cooling effectiveness.

    Abstract translation: 导管组件(2)包括导管轴(6),其具有具有中空内部(30)的尖端部分(10)和与远端间隔开的线性消融电极(18,34,46,44,58) 22)。 电极具有有效地流体地暴露于中空内部的内表面(28),使得穿过内部的冷却流体(32)接触内表面以便有效地冷却电极。 电极可以包括一系列带状电极(18,34)或一个或多个螺旋电极(36,44,58)。 用于制造尖端部分的一种方法包括将电极安装到心轴上,用聚合物填充电极的边缘(26)之间的空间,然后从心轴移除所得到的管状结构。 冷却流体可以通过中空螺旋电极(58),以提高冷却效果。

    Protective, visible suture sleeve for anchoring transvenous lead bodies
    187.
    发明授权
    Protective, visible suture sleeve for anchoring transvenous lead bodies 失效
    用于锚固经静脉引导体的保护性可见缝合套管

    公开(公告)号:US5628780A

    公开(公告)日:1997-05-13

    申请号:US387525

    申请日:1995-02-13

    Abstract: A suture sleeve for anchoring the lead body of an implantable medical device is fabricated of a biocompatible, polymeric material to which has been added color pigment in clear contrast with the bodily tissue adjacent the sleeve. The sleeve is therefore readily visible to the naked eye to aid the physician in locating the sleeve during lead implant or lead revision. Furthermore, the tubular body may be radiopaque and, therefore, easily seen on a fluoroscope through the addition of a radiologically dense material, such as tantalum powder, to the plastic from which the sleeve is molded.

    Abstract translation: 用于固定可植入医疗装置的引线体的缝合套管由生物相容的聚合物材料制成,已经与邻近套管的身体组织形成明显的颜色颜料。 因此,肉眼可以容易地看到套筒,以帮助医生在引线植入或引线修复期间定位套管。 此外,管状体可以是不透射线的,并且因此通过将放射致密材料(例如钽粉末)添加到成型套筒的塑料上而在荧光镜上容易地看到。

    Conductor for a defibrillator patch lead
    188.
    发明授权
    Conductor for a defibrillator patch lead 失效
    除颤器贴片导线导体

    公开(公告)号:US5324328A

    公开(公告)日:1994-06-28

    申请号:US926075

    申请日:1992-08-05

    CPC classification number: A61N1/0587 A61N1/05

    Abstract: An electrical conductor assembly utilized, for example, in a defibrillator patch lead to interconnect a pulse generator and monitoring unit, and a wire mesh electrode pad. The electrical conductor includes a Teflon insulated drawn brazed stranded (DBS) wire cable which is wrapped in a drawn filled tube (DFT) wire multifilar coil encased in a biocompatible insulative tubing.

    Abstract translation: 例如,在除颤器贴片中使用的电导体组件导致将脉冲发生器和监视单元互连,以及金属丝网电极垫。 电导体包括聚四氟乙烯绝缘拉伸铜焊绞线(DBS)线缆,其被缠绕在包裹在生物相容绝缘管中的拉伸填充管(DFT)线多线圈线圈中。

    Printer having global substitution list

    公开(公告)号:US09785390B2

    公开(公告)日:2017-10-10

    申请号:US14490972

    申请日:2014-09-19

    Abstract: A printer is described. The printer includes a processor. A memory is coupled to the processor. The memory contains instructions that when processed by the processor cause a method to be performed. The method includes presenting a list of printing substitutions on a display. The printing substitutions are each associated with a respective printer profile. The list of printing substitutions identify which ones of the printing substitutions are enabled and which ones of the printing substitutions are disabled. The list also identifies the printer profiles that the substitutions are associated with, wherein at least one printer profile that is not enabled for a current print job is included in the list.

Patent Agency Ranking